Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes
Schafer Boeder, MD describes the potential role and safety of adjunctive therapy, including SGLT2 inhibitors and GLP-1 agonists, for patients with T1D.
Schafer Boeder, MD describes the potential role and safety of adjunctive therapy, including SGLT2 inhibitors and GLP-1 agonists, for patients with T1D.
Founding Editor in Chief John Ayanian, MD, MPP, reflects on the origins and the highlights of the journal’s first 5 years, including seminal publications, the…
Application Deadline: January 4, 2021. The Morris Fishbein Fellowship in Medical Editing is a unique one-year fellowship opportunity offered by JAMA to introduce physicians to…
Digital healthcare consultations are not enough for a safe assessment of tonsillitis, according to a new study. Reliability will not be sufficient, thus increasing the…
TUESDAY, Oct. 8, 2024 (HealthDay News) — The brain has a waste-disposal system that clears away junk proteins that contribute to the development of dementia…
Does it feel like whenever you close your eyes to get some sleep, there’s a movie playing on repeat in your head without your permission?…
Eagle S, the Russia-linked tanker suspected of damaging an underwater electricity cable on Christmas Day, was kitted out with special transmitting and receiving devices that…
Glass skin, cloud skin, dolphin skin, neuro glow: Skin trends are nothing new in our digital world.
TUESDAY, Dec. 3, 2024 (HealthDay News) — Maintaining muscle might be one way to help prevent dementia, new research suggests.“We found that older adults with…
Now is a moment ripe for change
You may think your heart is as old as you are, but it’s possible that it’s aging faster than your chronological age.